Jinlian Ma

1.3k total citations · 1 hit paper
39 papers, 1.0k citations indexed

About

Jinlian Ma is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Jinlian Ma has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Physiology. Recurrent topics in Jinlian Ma's work include Epigenetics and DNA Methylation (12 papers), Histone Deacetylase Inhibitors Research (7 papers) and Cancer-related gene regulation (5 papers). Jinlian Ma is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Histone Deacetylase Inhibitors Research (7 papers) and Cancer-related gene regulation (5 papers). Jinlian Ma collaborates with scholars based in China, United States and Singapore. Jinlian Ma's co-authors include Yi‐Chao Zheng, Hong‐Min Liu, Wen Zhao, Jinfeng Li, Bin Yu, Ying‐Chao Duan, Xian-Wei Ye, Zhenqiang Zhang, He‐Dong Bian and Xueying Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and Journal of Agricultural and Food Chemistry.

In The Last Decade

Jinlian Ma

36 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High strength, controlled release of curcumin-loaded ZIF-8/chitosan/zein film with excellence gas barrier and antibacterial activity for litchi preservation

2023 106 citations Jinlian Ma et al. profile →

Peers

Jinlian Ma

BIOMA

ONCOL

Filiz Bakar‐Ates Türkiye

Xiaojun Gou China

Yuan‐Yuan Wang China

Huicui Yang China

Kumar Nikhil India

Fan Tang China

Shavkatjon Azizov Uzbekistan

С. Г. Клочков Russia

Farah Khan India

Filiz Bakar‐Ates Türkiye

Jinlian Ma

295 ×0.5

142 ×0.6

77 ×0.8

BIOMA

109 ×1.2

61 ×1.2

ONCOL

Citations per year, relative to Jinlian Ma Jinlian Ma (= 1×) peers Filiz Bakar‐Ates

Countries citing papers authored by Jinlian Ma

Since Specialization

Citations

This map shows the geographic impact of Jinlian Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinlian Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinlian Ma more than expected).

Fields of papers citing papers by Jinlian Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinlian Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinlian Ma. The network helps show where Jinlian Ma may publish in the future.

Co-authorship network of co-authors of Jinlian Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jinlian Ma. A scholar is included among the top collaborators of Jinlian Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinlian Ma. Jinlian Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Tiancheng, Zhonghua Li, Junying Song, et al.. (2025). Multi-target neuroprotection of Atractylodes macrocephala ethyl acetate extract against Alzheimer's disease: from bioactivity-guided screening to mechanistic validation. Journal of Ethnopharmacology. 355(Pt B). 120735–120735.

Sun, Tiancheng, et al.. (2025). Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy. European Journal of Medicinal Chemistry. 302(Pt 3). 118383–118383.

Liu, Ningning, Pan Wang, Ruiqin Sun, et al.. (2024). Proteomic analysis and experimental validation reveal the blood–brain barrier protective of Huanshaodan in the treatment of SAMP8 mouse model of Alzheimer’s disease. Chinese Medicine. 19(1). 137–137. 1 indexed citations

Yuan, Ye, Yamei Liu, Hao Li, et al.. (2023). The neuroprotective effects of Liuwei Dihuang medicine in the APP/PS1 mouse model are dependent on the PI3K/Akt signaling pathway. Frontiers in Pharmacology. 14. 1188893–1188893. 4 indexed citations

Liu, Ningning, Ruiqin Sun, Jinlian Ma, et al.. (2023). Radix Rehmanniae Praeparata (Shu Dihuang) exerts neuroprotective effects on ICV-STZ-induced Alzheimer’s disease mice through modulation of INSR/IRS-1/AKT/GSK-3β signaling pathway and intestinal microbiota. Frontiers in Pharmacology. 14. 1115387–1115387. 17 indexed citations

Zhang, Zijuan, Ziyang Yu, Shijie Wang, et al.. (2023). Cholecystokinin Signaling can Rescue Cognition and Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease. Molecular Neurobiology. 60(9). 5067–5089. 14 indexed citations

Sun, Yiran, Libo He, Pan Wang, et al.. (2023). Inhibition of ferroptosis through regulating neuronal calcium homeostasis: An emerging therapeutic target for Alzheimer’s disease. Ageing Research Reviews. 87. 101899–101899. 30 indexed citations

Li, Zhonghua, Pan Wang, Zijuan Zhang, et al.. (2023). Design, synthesis and in vitro/in vivo anticancer activity of tranylcypromine-based triazolopyrimidine analogs as novel LSD1 inhibitors. European Journal of Medicinal Chemistry. 253. 115321–115321. 8 indexed citations

Zhang, Zijuan, Hai Li, Jinlian Ma, et al.. (2022). Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model. Frontiers in Neuroscience. 16. 814430–814430. 22 indexed citations

10.

Li, Yu, Yuanyuan Zhao, Xiaona Li, et al.. (2022). Biological and therapeutic role of LSD1 in Alzheimer’s diseases. Frontiers in Pharmacology. 13. 1020556–1020556. 13 indexed citations

11.

Li, Zhonghua, Tingting Qin, Xuan Zhao, et al.. (2021). Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing. European Journal of Medicinal Chemistry. 225. 113778–113778. 20 indexed citations

12.

Li, Hongxia, et al.. (2020). Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1. Bioscience Reports. 40(1). 47 indexed citations

13.

Wang, Hongping & Jinlian Ma. (2019). Effects of chief nurses' integrity leadership and work environment on work adjustment in newly recruited nurses. Zhonghua xiandai huli zazhi. 25(7). 815–819. 3 indexed citations

14.

Zhou, Wenjuan, Liying Ma, Jing Yang, et al.. (2019). Potent and specific MTH1 inhibitors targeting gastric cancer. Cell Death and Disease. 10(6). 434–434. 28 indexed citations

15.

Li, Zhonghua, Jinlian Ma, Xinhui Zhang, et al.. (2019). [1,2,3]Triazolo[4,5-d]pyrimidine derivatives incorporating (thio)urea moiety as a novel scaffold for LSD1 inhibitors. European Journal of Medicinal Chemistry. 187. 111989–111989. 23 indexed citations

16.

Ma, Jinlian, et al.. (2018). Correlation of stigma, coping style and self-esteem among patients after breast modified radical mastectomy. Zhonghua xiandai huli zazhi. 24(3). 332–335. 1 indexed citations

17.

Li, Zhonghua, Ji Zhang, Xue‐Qi Liu, et al.. (2017). Identification of thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents through the drug repurposing strategy. European Journal of Medicinal Chemistry. 135. 204–212. 32 indexed citations

18.

Li, Zhonghua, Xue‐Qi Liu, Peng Geng, et al.. (2017). Design, synthesis and antiproliferative activity of thiazolo[5,4-d]pyrimidine derivatives through the atom replacement strategy. European Journal of Medicinal Chemistry. 138. 1034–1041. 11 indexed citations

19.

Zheng, Yi‐Chao, Jinlian Ma, Ying Liu, & Hong Liu. (2016). Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy. Current Pharmaceutical Design. 22(39). 5943–5947. 7 indexed citations

20.

Zheng, Yi‐Chao, Dandan Shen, Meng Ren, et al.. (2016). Baicalin, a natural LSD1 inhibitor. Bioorganic Chemistry. 69. 129–131. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact